Compare NG & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NG | AMPH |
|---|---|---|
| Founded | 1984 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 1.2B |
| IPO Year | 2002 | 2005 |
| Metric | NG | AMPH |
|---|---|---|
| Price | $14.23 | $21.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $10.83 | ★ $30.29 |
| AVG Volume (30 Days) | ★ 3.8M | 406.4K |
| Earning Date | 04-24-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.03 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | N/A | $8.00 |
| Revenue Next Year | N/A | $4.42 |
| P/E Ratio | ★ N/A | $9.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.26 | $19.83 |
| 52 Week High | $13.34 | $31.26 |
| Indicator | NG | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 70.66 | 25.89 |
| Support Level | $9.13 | $20.41 |
| Resistance Level | N/A | $22.90 |
| Average True Range (ATR) | 0.91 | 1.18 |
| MACD | 0.37 | -0.86 |
| Stochastic Oscillator | 98.66 | 12.39 |
Novagold Resources Inc operates in the gold mining industry, focused on advancing the Donlin Gold project in Alaska. The Donlin Gold project is held by Donlin Gold LLC (Donlin Gold), a limited liability company owned equally by wholly owned subsidiaries of NOVAGOLD and Barrick Gold Corporation (Barrick). The company includes exploration and development activities of gold and other precious metals.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.